Rising prevalence rate of immunodeficiency diseases also serves as a key driving factor for the plasma fractionation market growth. PIDD, multiple sclerosis, and immune thrombocytopenia purpura (ITP) are some of the examples of rare immune diseases that have high prevalence rate, globally.

Source: Click here